"This would augment our vaccine availability. Once this is available, whether it is through procurement or subsequent manufacturing," he said.
Bagchi also said that India has noted the announcement by the US on supplying COVID-19 vaccines to some countries.
The US announced earlier this week that it will share an additional 20 million coronavirus vaccine doses with other countries in addition to the 60 million it has already committed.
"We have, of course, noted the recent announcement by the US government of its intention to make some vaccines available to some other countries," Bagchi said.
He said all vaccines to be procured from abroad would need to be compliant with India's regulatory guidelines.
"I would like to emphasise that all vaccines that may be procured from abroad would need to be as per our regulatory guidelines. I understand that the US has also indicated that any vaccines it sends abroad would be after obtaining FDA (Food and Drug Administration) clearance for product quality," he said.
Recently, Charge D'Affaires of the US embassy Daniel B Smith said the US was looking at joint production of Johnson and Johnson's COVID-19 vaccines in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production.
As India was facing a rapid increase in coronavirus infections, the US deployed six planeloads of life-saving supplies in support of the country's fight against the pandemic. The US government's assistance to India is estimated at about USD 100 million.
To a separate question, Bagchi said a large number of countries have expressed solidarity with India in its fight against the second wave of the pandemic.
He said around 40 countries have sent medical equipment and other supplies.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.